10-Q: Verb Technology Company Reports Significant Revenue Growth in Q1 2025 Following Strategic Shift

Sentiment:

Quarterly Report


Verb Technology Company reports a substantial revenue increase in Q1 2025, driven by its MARKET.live and Go Fund Yourself business units, marking a significant shift following the divestiture of its SaaS assets.

Capital raiseThe company entered into a securities purchase agreement with Streeterville Capital, LLC.The company agreed to sell and the Investor agreed to purchase 5,000 shares of the Company's newly designated Non-Convertible, Non-Voting Series D Preferred Stock for a total purchase price of $5,000.The sale of the Shares was consummated on April 22, 2025.
Better than expectedRevenue increased significantly due to the growth of MARKET.live and Go Fund Yourself business units.Net loss decreased compared to the same period last year.

Summary

  • Verb Technology Company reported its Q1 2025 results, showing a significant increase in revenue compared to the same period last year.
  • Revenue for the quarter was $1.305 million, a substantial increase from $7,000 in Q1 2024.
  • This growth is primarily attributed to the MARKET.live and Go Fund Yourself business units.
  • The company's net loss for the quarter was $2.438 million, compared to a net loss of $3.445 million in Q1 2024.
  • The company completed the acquisition of LyveCom on April 11, 2025, aiming to enhance its MARKET.live platform with AI-driven video commerce capabilities.
  • Verb Technology also closed an equity financing deal on April 22, 2025, selling Series D Preferred Stock for $5 million.
  • As of March 31, 2025, the company had cash and restricted cash totaling $7.155 million and short-term investments of $5.081 million.

Sentiment

Score: 7

Explanation: The document presents a mixed sentiment. While there's significant revenue growth and strategic acquisitions, the company is still operating at a loss. The successful capital raise and positive outlook for MARKET.live contribute to a moderately positive sentiment.

Positives

  • Significant revenue growth driven by MARKET.live and Go Fund Yourself business units.
  • Decrease in net loss compared to the same period last year.
  • Acquisition of LyveCom to enhance the MARKET.live platform with AI capabilities.
  • Successful equity financing, raising $5 million through the sale of Series D Preferred Stock.
  • The company fully repaid the SBA loan balance, including accrued interest, on March 7, 2025.

Negatives

  • The company continues to incur net losses, with a net loss of $2.438 million for Q1 2025.
  • General and administrative expenses remain high at $3.331 million for the quarter.
  • The company is still involved in a legal dispute with a former employee, although a bond has been posted to prevent enforcement of the judgment during the appeal process.

Risks

  • The company's business is dependent on general economic conditions, which could negatively affect demand for its products.
  • The company faces risks related to growing and competing in the future and executing its business strategy.
  • The company's ability to maintain compliance with the listing requirements of the Nasdaq Capital Market is a risk factor.
  • The company is susceptible to security breaches and other disruptions.

Future Outlook

The company expects that the MARKET.live business unit will create greater shareholder value over time. The integration of LyveCom's technology is expected to allow brands and merchants to deliver a true omnichannel livestream shopping experience. The company intends to employ MARKET.live's social commerce technology to disrupt the traditional healthcare model through Vanity Prescribed.

Management Comments

  • Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations that period.

Industry Context

The company is operating in the growing social commerce and livestream shopping market, leveraging partnerships with platforms like TikTok and Meta. The acquisition of LyveCom positions the company to offer a more comprehensive omnichannel solution for brands and merchants. The launch of Vanity Prescribed aligns with the increasing trend of telehealth and online pharmaceutical services, similar to companies like HIMS and HERS.

Comparison to Industry Standards

  • The company's shift towards social commerce and livestream shopping aligns with industry trends, as seen with companies like TalkShopLive and NTWRK.
  • The MARKET.live platform competes with other multi-vendor livestream shopping destinations.
  • The Vanity Prescribed initiative positions the company in the telehealth market, competing with companies like HIMS and HERS.
  • The Go Fund Yourself platform is unique in its combination of a reality TV show with crowdfunding, differentiating it from traditional crowdfunding platforms like Kickstarter and Indiegogo.

Legal Proceedings

  • The Company is currently in a dispute with a former employee of its predecessor bBooth, Inc. who has interposed a breach of contract claim.
  • The Company filed a timely appeal from the judgment (Meyerson v. Verb Technology Company, Inc. (2023 2nd Appellate District) Case No.: B334777, seeking among other things, that the trial courts finding be vacated and that the Companys affirmative defenses be reinstated.
  • As of this date, the appeal has yet to be heard.
  • In the interim, the Company bonded the judgement preventing any enforcement or collection of the judgement while the appeal is pending.

Stakeholder Impact

  • Shareholders: The revenue growth and strategic acquisitions are positive for shareholders, but the ongoing losses are a concern.
  • Employees: The company's growth and new initiatives may create new opportunities for employees.
  • Customers: The enhanced MARKET.live platform and new services from Vanity Prescribed could benefit customers.
  • Suppliers: Increased business activity could lead to more opportunities for suppliers.

Next Steps

  • Continue integrating LyveCom's technology into the MARKET.live platform.
  • Focus on growing revenue from the MARKET.live, Go Fund Yourself, and Vanity Prescribed business units.
  • Manage expenses and work towards achieving profitability.
  • Monitor and address any potential risks related to economic conditions and competition.

Key Dates

DateDescription
2020-05-15Company executed an unsecured loan with the SBA under the Economic Injury Disaster Loan program.
2023-06-13The Company disposed of all of its operating SaaS assets.
2025-03-04Verb announced the execution of a binding term sheet to acquire LyveCom.
2025-03-07The Company fully repaid the SBA loan balance, including accrued interest.
2025-03-11The Company announced the launch of GoodGirlRx.com, a partnership under Vanity Prescribed with Savannah Chrisley.
2025-03-31End of the quarterly period.
2025-04-11The Company, Lyvecom and the Lyvecom Shareholders entered into a definitive Stock Purchase Agreement with respect to the Acquisition that incorporated the terms of the Binding Term Sheet.
2025-04-17Verb announced the closing of the acquisition of LyveCom.
2025-04-22The Company entered into a securities purchase agreement with Streeterville Capital, LLC.
2025-04-23The Company filed a certificate of designation of preferences and rights of Series D Non-Convertible Preferred Stock.
2025-05-08Date as of which there were 1,417,955 shares of common stock outstanding.
2025-05-13Date of report filing.

Keywords

MARKET.live, GoFundYourself, LyveCom, social commerce, livestream shopping, revenue growth, financial results, acquisition, equity financing, Verb Technology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.